West Molesey, United Kingdom
IPS Pharma, founded in 2001, operates as an independent international pharmaceutical services company headquartered in the United Kingdom. Focusing on Biotechnology, Manufacturing, and Pharmaceutical domains, the company's core areas include Unlicensed Medicines, Clinical Trials, and Special Obtains, generating significant attention within its industry.
Notably, IPS Pharma boasts a robust infrastructure with a state-of-the-art facility in Surrey capable of delivering over 20,000 formulations of unlicensed medicines, enhancing their competitive edge. They maintain a global sourcing network vetted to ensure timely, high-quality product delivery. Compliance with the Medicines and Healthcare products Regulatory Agency (MHRA) underscores their commitment to ethical practices and industry standards.
Despite the absence of recent investment rounds, IPS Pharma stands out for its collaboration with healthcare professionals and dedication to improving patient outcomes. Their renowned expertise and ongoing investment in technology and personnel affirm their market relevance and growth potential.
